Delivery Order SPE2DB22D1106-SPE2DB25FFDZ3
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Metronidazole 250 mg tablets (250 count) with a ceiling value of $1,809.50. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metronidazole 500mg tablets (500 count) with a ceiling value of $7,360.33. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting...
- The U.S. Defense Department's Medical Supply Chain awarded a $10,353.77 delivery order to AmerisourceBergen Drug Corp for the supply of Metronidazole 60GM on July 30, 2025, with an ultimate completion date of August 26, 2025. This competitive award, which utilized no set-aside designation, is structured as a firm fixed-price delivery order to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $86,300 for 100 tablets of 250mg metronidazole. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order has a period of performance from June 22, 2023 through June 23, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the Department of Defense, this delivery order is likely associated with...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $158,000 delivery order contract to supply 500 boxes of 250mg Metronidazole tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 24, 2023 under a firm fixed price contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,046.90, is for the supply of Metronidazole Tablets, a pharmaceutical product, to support military treatment programs and facilities. The award has no set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- This is a delivery order (SPE2DB24FBFM0) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of 4,565,618,656 units of Metronidazole 500 mg tablets. The order, which is not set-aside, has a ceiling value of $3,438.61 and an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a...
- Amerisourcebergen Drug Corp has been awarded a $958 firm fixed price delivery order contract from the Defense Logistics Agency to supply 500 tablets of 500 milligrams of metronidazole, an antibiotic medication. The place of performance will be in Conshohocken, Pennsylvania and all tablets must be delivered by September 27, 2023. No set-aside provisions were applied to this award, which was issued against an unidentified agency-wide contract vehicle to fulfill pharmaceutical supply needs....
- This federal contract award, valued at $1,177.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Metronidazole 500 mg tablets, a generic drug used to treat various bacterial and parasitic infections. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Metronidazole 0.75% cream in 45-gram units, valued at $1,590.68. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carried no set-aside...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDZ3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Metronidazole 500 mg tablets in quantities of 100 units, with a ceiling value of $3,856.60 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 20, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor to federal medical procurement programs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. Metronidazole is a commonly prescribed antibiotic used in military and veteran healthcare systems, and this particular delivery order reflects the routine pharmaceutical procurement activities conducted through the broader DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/19/25 |